Results
1140
Most Popular Stocks on the market
1140 companies
Psyence Biomedical
Market Cap: US$1.9m
Engages in the development of botanical psilocybin-based psychedelic medicines.
PBM
US$3.07
7D
-42.1%
1Y
-95.3%
Nascent Pharma Holdings
Market Cap: US$1.9m
Engages in the protection and commercialization of cannabis patents.
NASC
US$0.021
7D
-17.2%
1Y
168.8%
Enveric Biosciences
Market Cap: US$1.9m
A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.
ENVB
US$0.61
7D
-3.2%
1Y
-91.5%
Breakthrough Chemistry
Market Cap: US$1.8m
Develops compounds and formulations that defy the norms prevalent in chemical industries.
BKTH
US$0.19
7D
90.0%
1Y
-54.4%
Kaya Holdings
Market Cap: US$1.8m
A vertically integrated legal cannabis enterprise, operates psychedelic treatment clinics and medical cannabis dispensaries in the United States.
KAYS
US$0.052
7D
5.3%
1Y
10.5%
Resonate Blends
Market Cap: US$1.8m
Engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine.
KOAN
US$0.013
7D
63.4%
1Y
68.6%
Agentix
Market Cap: US$1.8m
A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.
AGTX
US$0.045
7D
28.6%
1Y
-10.0%
OMID Holdings
Market Cap: US$1.8m
A health and wellness company, engages in the manufacture and sale of CBD-based products.
OMID
US$0.019
7D
1.3%
1Y
-23.4%
AXIM Biotechnologies
Market Cap: US$1.8m
Develops diagnostic healthcare solutions for ophthalmological conditions.
AXIM
US$0.0052
7D
13.8%
1Y
-14.8%
Evofem Biosciences
Market Cap: US$1.7m
A biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.
EVFM
US$0.014
7D
4.6%
1Y
48.9%
CBD Life Sciences
Market Cap: US$1.7m
Engages in the development and marketing a line of cannabidiol based organic products.
CBDL
US$0.0004
7D
33.3%
1Y
-33.3%
Endexx
Market Cap: US$1.6m
Develops and sells hemp-derived products for the health and wellness market under the CBD Unlimited brand in the United States and internationally.
EDXC
US$0.0025
7D
-15.3%
1Y
-79.3%
Vaccinex
Market Cap: US$1.6m
A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.
VCNX
US$0.55
7D
-21.4%
1Y
-83.2%
LiveCare
Market Cap: US$1.5m
Focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.
LVCE
US$0.025
7D
0%
1Y
-91.6%
Longevity Health Holdings
Market Cap: US$1.5m
A bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products.
XAGE
US$0.90
7D
-9.8%
1Y
-92.0%
Body and Mind
Market Cap: US$1.5m
Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, Illinois, and New Jersey in the United States.
BMMJ
US$0.01
7D
0%
1Y
-65.3%
Enzolytics
Market Cap: US$1.4m
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
ENZC
US$0.0003
7D
0%
1Y
-83.3%
ZyVersa Therapeutics
Market Cap: US$1.4m
Operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases.
ZVSA
US$0.18
7D
10.1%
1Y
-92.3%
AJ1G
Market Cap: US$1.3m
Global Consortium Inc. operates as a diversified cannabis holding company in Florida.
AJYG
US$0.022
7D
0%
1Y
n/a
Galera Therapeutics
Market Cap: US$1.3m
A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.
GRTX
US$0.018
7D
-10.0%
1Y
-74.7%
Allied
Market Cap: US$1.3m
A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.
ALID
US$0.011
7D
0%
1Y
-78.7%
American Green
Market Cap: US$1.3m
Operates as a technology company in the medical cannabis industry in the United States.
ERBB
US$0.0003
7D
0%
1Y
0%
Ocean Biomedical
Market Cap: US$1.3m
A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.
OCEA
US$0.0056
7D
-9.7%
1Y
-99.4%
Halberd
Market Cap: US$1.2m
A biotech company, develops treatments for neurodegenerative diseases.
HALB
US$0.0019
7D
-12.6%
1Y
-62.6%
Biomind Labs
Market Cap: US$1.2m
A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.
BMND.F
US$0.016
7D
0%
1Y
-96.8%
Nascent Biotech
Market Cap: US$1.2m
A clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer.
NBIO
US$0.007
7D
-17.6%
1Y
-85.0%
GelStat
Market Cap: US$1.1m
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.
GSAC
US$0.0003
7D
-25.0%
1Y
0%
Petros Pharmaceuticals
Market Cap: US$1.1m
A healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.
PTPI
US$0.026
7D
-8.6%
1Y
-99.7%
VG Life Sciences
Market Cap: US$1.1m
A biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.
VGLS
US$0.0001
7D
0%
1Y
0%
Core One Labs
Market Cap: US$1.1m
Operates as a psychedelic research and development company.
CLAB.F
US$0.022
7D
10.4%
1Y
-75.9%
Target Group
Market Cap: US$1.0m
Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.
CBDY
US$0.0017
7D
0%
1Y
-19.0%
AXM Pharma
Market Cap: US$1.0m
Manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China.
AXMP
US$0.0001
7D
0%
1Y
n/a
International Stem Cell
Market Cap: US$1.0m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.13
7D
-8.5%
1Y
83.1%
Premier Biomedical
Market Cap: US$1.0m
A research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases.
BIEI
US$0.00074
7D
-6.3%
1Y
-26.0%
Unity Biotechnology
Market Cap: US$1.0m
A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.
UNBX
US$0.06
7D
0%
1Y
-95.8%
EV Biologics
Market Cap: US$984.7k
A biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.
YECO
US$0.096
7D
11.1%
1Y
-67.4%